dimethylarginine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthases. By inhibiting nitric oxide formation…
Background—Endothelial function is impaired by hyperhomocyst(e)inemia. We have previously shown that homocyst(e)ine (Hcy…
Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), may be related to reduced…
BACKGROUND
Exposure to risk factors such as hypertension or hypercholesterolemia decreases the bioavailability of endothelium…
1 Dimethylarginine dimethylaminohydrolase (DDAH), an enzyme that metabolizes the endogenous nitric oxide synthase inhibitors NG…